Overview of the Role of Pharmacological Management of Obstructive Sleep Apnea.

Bibliographic Details
Title: Overview of the Role of Pharmacological Management of Obstructive Sleep Apnea.
Authors: Arredondo, Enrique, DeLeon, Monica, Masozera, Ishimwe, Panahi, Ladan, Udeani, George, Tran, Nhan, Nguyen, Chi K., Atphaisit, Chairat, de la Sota, Brooke, Gonzalez Jr., Gabriel, Liou, Eileen, Mayo, Zack, Nwosu, Jennifer, Shiver, Tori L.
Source: Medicina (1010660X); Feb2022, Vol. 58 Issue 2, p225, 1p
Subject Terms: SLEEP apnea syndrome treatment, DISEASE management, HUMAN phenotype, DISEASE relapse, CONTINUOUS positive airway pressure, POTASSIUM antagonists
Abstract: Obstructive sleep apnea (OSA) remains a prominent disease state characterized by the recurrent collapse of the upper airway while sleeping. To date, current treatment may include continuous positive airway pressure (CPAP), lifestyle changes, behavioral modification, mandibular advancement devices, and surgical treatment. However, due to the desire for a more convenient mode of management, pharmacological treatment has been thoroughly investigated as a means for a potential alternative in OSA treatment. OSA can be distinguished into various endotypic or phenotypic classes, allowing pharmacological treatment to better target the root cause or symptoms of OSA. Some medications available for use include antidepressants, CNS stimulants, nasal decongestants, carbonic anhydrase inhibitors, and potassium channel blockers. This review will cover the findings of currently available and future study medications that could potentially play a role in OSA therapy. [ABSTRACT FROM AUTHOR]
Copyright of Medicina (1010660X) is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Database: Complementary Index
More Details
ISSN:1010660X
DOI:10.3390/medicina58020225
Published in:Medicina (1010660X)
Language:English